Anti-HVEM antibody [DM131] (STJA0038113)

SKU:
STJA0038113-100
£432.50
Free Shipping
Processing The item has been added

Host: Rabbit
Applications: FC/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Rabbit monoclonal anti-HVEM for use in FC and ELISA in Human samples. Datasheet included with dilution recommendations, and related reagents.
Clonality : Monoclonal
Clone ID : DM131
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.
Purification: Affinity Chromatography
Dilution Range: FC 1:50-1:100
ELISA 1:10000
Storage Instruction: Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.
Gene Symbol: TNFRSF14
Gene ID: 8764
Uniprot ID: TNR14_HUMAN
Immunogen: Recombinant human HVEM protein
Tissue Specificity Widely expressed, with the highest expression in lung, spleen and thymus. Expressed in a subpopulation of B cells and monocytes. Expressed in naive T cells.
Post Translational Modifications N-glycosylated.
Function Receptor for four distinct ligands: The TNF superfamily members TNFSF14/LIGHT and homotrimeric LTA/lymphotoxin-alpha and the immunoglobulin superfamily members BTLA and CD160, altogether defining a complex stimulatory and inhibitory signaling network. Signals via the TRAF2-TRAF3 E3 ligase pathway to promote immune cell survival and differentiation. Participates in bidirectional cell-cell contact signaling between antigen presenting cells and lymphocytes. In response to ligation of TNFSF14/LIGHT, delivers costimulatory signals to T cells, promoting cell proliferation and effector functions. Interacts with CD160 on NK cells, enhancing IFNG production and anti-tumor immune response. In the context of bacterial infection, acts as a signaling receptor on epithelial cells for CD160 from intraepithelial lymphocytes, triggering the production of antimicrobial proteins and pro-inflammatory cytokines. Upon binding to CD160 on activated CD4+ T cells, down-regulates CD28 costimulatory signaling, restricting memory and alloantigen-specific immune response. May interact in cis (on the same cell) or in trans (on other cells) with BTLA. In cis interactions, appears to play an immune regulatory role inhibiting in trans interactions in naive T cells to maintain a resting state. In trans interactions, can predominate during adaptive immune response to provide survival signals to effector T cells. (Microbial infection) Acts as a receptor for Herpes simplex virus 1/HHV-1. (Microbial infection) Acts as a receptor for Herpes simplex virus 2/HHV-2.
Protein Name Tumor Necrosis Factor Receptor Superfamily Member 14
Herpes Virus Entry Mediator A
Herpesvirus Entry Mediator A
Hvea
Tumor Necrosis Factor Receptor-Like 2
Tr2
Cd Antigen Cd270
Database Links Reactome: R-HSA-5669034
Reactome: R-HSA-9927353
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-Tumor Necrosis Factor Receptor Superfamily Member 14 antibody
Anti-Herpes Virus Entry Mediator A antibody
Anti-Herpesvirus Entry Mediator A antibody
Anti-Hvea antibody
Anti-Tumor Necrosis Factor Receptor-Like 2 antibody
Anti-Tr2 antibody
Anti-Cd Antigen Cd270 antibody
Anti-TNFRSF14 antibody
Anti-HVEA antibody
Anti-HVEM antibody
Anti-UNQ329 antibody
Anti-PRO509 antibody

Information sourced from Uniprot.org